CN102895489A - Chinese medicinal composition for treating cat infectious bovine rhinotracheitis - Google Patents
Chinese medicinal composition for treating cat infectious bovine rhinotracheitis Download PDFInfo
- Publication number
- CN102895489A CN102895489A CN2012104244839A CN201210424483A CN102895489A CN 102895489 A CN102895489 A CN 102895489A CN 2012104244839 A CN2012104244839 A CN 2012104244839A CN 201210424483 A CN201210424483 A CN 201210424483A CN 102895489 A CN102895489 A CN 102895489A
- Authority
- CN
- China
- Prior art keywords
- parts
- cat
- heat
- rhizoma
- infectious bovine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicinal composition for treating cat infectious bovine rhinotracheitis. The Chinese medicinal composition comprises the following components in parts by weight: 1-450 parts of coptis root, 1-450 parts of baikal skullcap root, 1-400 parts of figwort, 1-300 parts of rhubarb, 1-250 parts of skunk bugbane, 1-250 parts of gypsum and 1-250 parts of common anemarrhena. A Chinese veterinarian dialectical therapy method is adopted; coptis root has the effects of clearing heat, drying dampness, purging intense heat and detoxifying; baikal skullcap root is used for treating symptoms such as a warm heat disease, upper respiratory tract infection, cough with lung heat and the like; figwort has the effects of removing pathogenic heat from blood, purging intense heat, detoxifying and nourishing yin; rhubarb has the effects of eliminating food retention in stomach, clearing away damp-heat, discharging fire, cooling blood, removing blood stasis and detoxifying; and coptis root, baikal skullcap root, figwort, rhubarb, skunk bugbane, gypsum and common anemarrhena co-act with each other, so that cat infectious bovine rhinotracheitis can be treated effectively.
Description
Technical field
The invention belongs to field of traditional Chinese veterinary, especially relate to a kind of Chinese medicine composition for the treatment of the cat infectious bovine rhinotracheitis.
Background technology
The cat infectious bovine rhinotracheitis is a kind of acute, the height contact upper respiratory disease of the cat that caused by felid herpesvirus 1 type (FHV-1).Because now vagrant cat is more, community feeds intensive, and breeding is many, and the primary disease morbidity that wanders around in the cat particularly in the new cub cat is high, infects soon, and mortality rate reaches 50% approximately.
FHV-1 belongs to herpetoviridae in classification, and first type herpesvirus subfamily has the general features of herpesvirus.FHV-1 only has a serotype; FHV-1 to external world the environment resistance a little less than, responsive to acid, heat and fatsolvent; Formaldehyde and phenol are easily killed it.Under-60 ℃ of conditions, can survive 180 deactivation in 4～5 minutes under 50 ℃ of conditions.Under drying condition, got final product deactivation with interior in 12 hours.Adsorbable and the coagulation cat erythrocyte of FHV-1 can adopt hemagglutination test and hemagglutination inhibition test to detect virus antigen and antibody.
FHV-1 mainly is communicated by contact, the secretions of virus per nasal, eye, pharynx is discharged, and the susceptible cat contacts by nose and nose direct and suction contains the viral spittle through respiratory tract infection, anti-the cat of spontaneous remission or artificial vaccination, can be with for a long time poison and toxin expelling, become dangerous source of infection.FHV-1 has the species specificity of height simultaneously, is detected in cat, but can causes also that sometimes other animals of cat family infect, and is not pathogenic to other animals beyond the cat family.
About 2～6 days of incubation period of primary disease, young cat is than adult cat easy infection and serious symptom.At the beginning of the disease, suffer from the cat fervescence, upper respiratory tract infection symptoms is obvious, show as to break out, paroxysmal sneeze and cough, photophobia, shed tears, the conjunctiva inflammation, nasal secretion increases, loss of appetite loses weight, spirit is depressed.Nasal cavity and turbinates mucosa are diffusivity hyperemia, and larynx and trachea also similar variation can occur, and nose liquid and tear initial stage are transparent, after become glutinous purulence.The acute case symptom was held 10～14 usually, and the adult cat mortality rate is lower, and death can occur the ill young cat of about half, and mortality rate is higher when merging the antibacterial infection.Being with malicious female cat to produce new cub cat can fall ill, asthenia, drowsiness, ventral breathing or asymptomatic death; The sick cat of anti-mistake after 7 days symptom alleviate gradually and fully recover; The sick cat of part then transfers to chronic, performance persistent cough, dyspnea and sinusitis symptom.Serious case, usually nasal cavity and turbinates mucosa are downright bad, focal necrosis also occurs in eye conjunctiva, tonsil, epiglottic cartilage, larynx, trachea, bronchus even bronchiolar part mucosal epithelium, visible a large amount of acidophilic intranuclear inclusions in the epithelial cell of necrotic area.For the young cat of systemic infection, also visible acidophilic intranuclear inclusion of the cell in local necrosis zone around the blood vessel.Show simultaneously the sick cat of lower respiratory tract symptom, visible interstitial pneumonia and bronchus and bronchiolitis surrounding tissue are downright bad, sometimes the pathological changes of visible tracheitis and bronchiolitis.
From clinical symptoms, cat infectious bovine rhinotracheitis associated diseases and feline calicivirus infection, cat distemper and cat's flu are difficult to difference, only have by specific serological reaction or pathogen separation and just can make Accurate Diagnosis.The most reliable diagnosis is isolated viral.In addition, the cat infectious bovine rhinotracheitis also has similar symptom to the upper respiratory disease that is caused by viruses such as mycoplasma, reovirus, caliciviruses in clinical manifestation.Their Differential Diagnosis main points are as follows:
(1) the upper respiratory tract disease main manifestations that causes of mycoplasma is anorexia, fervescence and drowsiness, but sometimes not lasting.One-sided or bilateral eye conjunctivitis, the order of severity of two ophthalmia disease processes is inconsistent, blepharospasm, the conjunctive bulbi edema, eye has serosity or mucopurulent secretion thing, usually shows without pneumonia.
(2) the upper respiratory tract disease clinical symptoms that causes of reovirus is lighter, the performance photophobia that keeps in dark place, and eye has a small amount of serosity secretions.The Chang Bubi treatment can be healed.
(3) the upper respiratory tract disease clinical manifestation anorexia, the fervescence that cause of calicivirus, tongue, hard hip, nasal mucosa have ulcer, the oral cavity sialorrhea, nasal cavity has secretions, and the inflammation of eye conjunctiva is shed tears.Pneumonia can occur in serious case, and dyspneic symptom is arranged.
Primary disease may have heritability except having infectiousness, namely should disease virus may cause the fetal zone poison by placental infection to fetus, can be ill after the young cat birth, asthenia, drowsiness, ventral breathing or asymptomatic death.Because the cat infectious bovine rhinotracheitis is by respiratory tract or transmission, by direct contact, and mainly be to contain the viral spittle by suction to propagate, so this disease presents the contagiousness of height.Recent study proves, the cat of spontaneous remission or artificial vaccination, and band poison and toxin expelling that can be long-term become the dangerous source of infection, think that simultaneously primary disease probably as a lot of herpesviruss, has the character of latent infection.Therefore, be difficult to be eliminated in this disease of occurring in nature, and be difficult to judge that certain cat is with poison, this just controls this disease to us and has caused a very large obstacle.
Cat infectious bovine rhinotracheitis disease is the low-down disease of a kind of cure rate, and its cure rate only 12.5% still lacks specific drug at present.At present general treatement is many prevents the secondary infection of disease cat antibacterial with broad ectrum antibiotic, and preventing the generation of sequela, but cure rate is still lower, often can not effect a radical cure.
Summary of the invention
In order to overcome above-mentioned deficiency, the invention provides a kind of Chinese medicine composition for preparing treatment cat infectious bovine rhinotracheitis simple, evident in efficacy.
Concrete technical scheme of the present invention is: a kind of Chinese medicine composition for the treatment of the cat infectious bovine rhinotracheitis, meter comprises following component by weight: Rhizoma Coptidis 1-450 part, Radix Scutellariae 1-450 part, Radix Scrophulariae 1-400 part, Radix Et Rhizoma Rhei 1-300 part, Rhizoma Cimicifugae 1-250 part, Gypsum Fibrosum 1-250 part, Rhizoma Anemarrhenae 1-250 part.
Preferably, above-mentioned Chinese medicine composition is counted by weight and is comprised following component:.
The using method of above-mentioned Chinese medicine composition is: during treatment, above-mentioned Chinese medicine composition is mixed in the 1:4-20 ratio in parts by weight with water, decoction, serve on for 1 ~ 2 week at 1 dose of every cat every day.
The present invention adopts the method for the dialectical treatment of Chinese veterinarian, utilizes Rhizoma Coptidis to have the effect of heat clearing and damp drying, eliminating fire and detoxication; The diseases such as scutellaria for treating epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat; Radix Scrophulariae has the effect of clearing away heat and cooling blood, eliminating fire and detoxication, YIN nourishing, and Radix Et Rhizoma Rhei has the effect of attacking stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling detoxifcation; The cat infectious bovine rhinotracheitis is effectively treated in Rhizoma Coptidis, Radix Scutellariae, Radix Scrophulariae, Radix Et Rhizoma Rhei and Rhizoma Cimicifugae, Gypsum Fibrosum, Rhizoma Anemarrhenae combined effect.
Should note during this disease in treatment: suffer from cat's whisker and isolate early, note insulation, if any dehydration, can be oral or subcutaneous injection etc. ooze glucose saline, be appetite stimulator, can give and a small amount of fragrance food, be conducive to the rehabilitation of moulting.
Having on the market at present weak malicious Seedling can be for prevention, and cat carries out head after two months exempts from, every injecting once more all around, annual later on.
In addition, be with malicious female cat should not remake kind of a usefulness; Strengthening feeding and management is the basic measures of prevention primary disease; Should reduce stressors at ordinary times as far as possible, cat is brought up in the draughty environment; New introduction cat or young cat should be observed two weeks of isolation at least.Reduce cat group's quantity and density, strengthen keeper's Personal hygiene and all primary disease is prevented to have certain benefit.
The specific embodiment
The invention will be further described below by specific embodiment, and following examples are descriptive, is not determinate, can not limit protection scope of the present invention with this.
Embodiment 1
Sick cat clinical symptoms: spirit is depressed, does not have appetite, and is disorderly thick by hair, tarnishes, and the paroxysmal cough appears in fervescence, sheds tears, and the performance of conjunctivitis is arranged; Nasal cavity has a large amount of secretions, and beginning is serosity, after change pus into; There is ulcer in the oral cavity, continuously outflows purulent secretion, frowziness from mouth.According to cat master introduction, he once had 1 younger cats of only having cold symptoms in the street in one's care before this cat is sick, and after 3 days, the younger cats after this is had in one's care is soon because respiratory failure and death.Simultaneously, flu-like symptoms have also appearred in other cats, rhinorrhea occurs, drop tears etc., and are accompanied by the decline of appetite, and spirit is depressed.
Adopt the present invention program: Rhizoma Coptidis 45g, Radix Scutellariae 45g, Radix Scrophulariae 40g, Radix Et Rhizoma Rhei 30g, Rhizoma Cimicifugae 25g, Gypsum Fibrosum 25g, Rhizoma Anemarrhenae 25g, during treatment, with above-mentioned Chinese medicine composition and water, mix decoction, 1 dose of every cat every day in the 1:10 ratio in parts by weight, serve on for 1 week, cure.
More than preferred embodiment of the present invention is had been described in detail, but described content only is preferred embodiment of the present invention, can not be considered to be used to limiting practical range of the present invention.All equalizations of doing according to the present patent application scope change and improve etc., all should still belong within the patent covering scope of the present invention.
Claims (3)
1. Chinese medicine composition for the treatment of the cat infectious bovine rhinotracheitis is characterized in that counting by weight and comprises following component: Rhizoma Coptidis 1-450 part, Radix Scutellariae 1-450 part, Radix Scrophulariae 1-400 part, Radix Et Rhizoma Rhei 1-300 part, Rhizoma Cimicifugae 1-250 part, Gypsum Fibrosum 1-250 part, Rhizoma Anemarrhenae 1-250 part.
2. Chinese medicine composition as claimed in claim 1 is characterized in that counting by weight and comprises following component: 45 parts of Rhizoma Coptidis, 45 parts of Radix Scutellariaes, 40 parts of Radix Scrophulariaes, 30 parts of Radix Et Rhizoma Rhei, 25 parts of Rhizoma Cimicifugaes, 25 parts in Gypsum Fibrosum, 25 parts of the Rhizoma Anemarrhenaes.
3. the using method of Chinese medicine composition is as claimed in claim 1 or 2: during treatment, described Chinese medicine composition is mixed in the 1:4-20 ratio in parts by weight with water, decoction, serve on for 1 ~ 2 week at 1 dose of every cat every day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104244839A CN102895489A (en) | 2012-10-30 | 2012-10-30 | Chinese medicinal composition for treating cat infectious bovine rhinotracheitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104244839A CN102895489A (en) | 2012-10-30 | 2012-10-30 | Chinese medicinal composition for treating cat infectious bovine rhinotracheitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102895489A true CN102895489A (en) | 2013-01-30 |
Family
ID=47568175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104244839A Pending CN102895489A (en) | 2012-10-30 | 2012-10-30 | Chinese medicinal composition for treating cat infectious bovine rhinotracheitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895489A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177156A (en) * | 2016-08-25 | 2016-12-07 | 中国农业科学院兰州畜牧与兽药研究所 | A kind of Chinese medicine composition preventing and treating infectious bovine rhinotrachetis and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102648966A (en) * | 2011-02-28 | 2012-08-29 | 周国生 | Scourge-clearing toxin-vanquishing soup |
-
2012
- 2012-10-30 CN CN2012104244839A patent/CN102895489A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102648966A (en) * | 2011-02-28 | 2012-08-29 | 周国生 | Scourge-clearing toxin-vanquishing soup |
Non-Patent Citations (3)
| Title |
|---|
| 尚太成等: "运用传统兽医学诊治犬猫疾病的认识与实践", 《全国兽医外科学第13次学术研讨会小动物医学第1次学术研讨会暨奶牛疾病第3次学术讨论会论文集》 * |
| 王田: "猫传染性鼻气管炎的诊断与治疗", 《中国畜牧兽医文摘》 * |
| 陈庆勋等: "中西医结合治疗奶牛传染性鼻气管炎", 《浙江畜牧兽医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177156A (en) * | 2016-08-25 | 2016-12-07 | 中国农业科学院兰州畜牧与兽药研究所 | A kind of Chinese medicine composition preventing and treating infectious bovine rhinotrachetis and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101773594B (en) | Composition for treating sheep diarrhea and preparation method thereof | |
| CN105311048A (en) | Application of houttuynia cordata polysaccharide in preparation of drugs for preventing and treating influenza A and viral pneumonia | |
| CN101439090A (en) | Formulation containing honeysuckle flower and scutellaria, and uses thereof | |
| CN102038100A (en) | Feed additive for preventing and treating swine fever | |
| CN108969492B (en) | Oral attenuated freeze-dried vaccine for swine fever and preparation method thereof | |
| CN102657804B (en) | Traditional Chinese medical composition for treatment of viral influenza and preparation method thereof | |
| CN103784538A (en) | Traditional Chinese medicinal compound drug for effectively preventing and treating swine influenza | |
| US20230080878A1 (en) | Application of traditional chinese medicine composition in preparation of drugs for treating or preventing coronavirus infection | |
| CN102988469A (en) | Traditional Chinese medicine composition for preventing and treating influenza virus infection as well as preparation method and application thereof | |
| CN102895489A (en) | Chinese medicinal composition for treating cat infectious bovine rhinotracheitis | |
| CN103638147A (en) | Traditional Chinese medicine compound for resisting swine influenza virus | |
| CN102283838B (en) | Application of ethoxysanguinarine to pharmacy | |
| CN109589352B (en) | Application of polygonum chinense polysaccharide in preparation of medicine for preventing and treating viral pneumonia | |
| CN106924402B (en) | Chinese medicinal compound preparation for preventing and treating influenza and viral pneumonia | |
| CN108186866B (en) | Application of golden scallop oral liquid in antivirus | |
| WO2012129949A1 (en) | Use of traditional chinese medicine composition in preparation of anti-enterovirus 71 drug | |
| CN105832848A (en) | Traditional Chinese medicine composition for poultry respiratory diseases and preparation method thereof | |
| CN110051682B (en) | Application of polysaccharide of thuja in preparation of medicine for preventing and treating viral acute lung injury | |
| CN101411752A (en) | Granular formulation for treating children's pneumonia | |
| CN104013884A (en) | Traditional Chinese medicine composition for treating pediatric bronchitis | |
| CN103585360A (en) | Traditional Chinese medicinal preparation for treating upper respiratory tract infection | |
| CN113786404A (en) | Application of bromophenol-pyrazoline compound in treating avian coronavirus diseases | |
| CN106177156A (en) | A kind of Chinese medicine composition preventing and treating infectious bovine rhinotrachetis and application thereof | |
| CN105232763A (en) | Traditional Chinese medicine combination for treating avian respiratory tract infection and preparation method and application thereof | |
| CN104524291A (en) | Method for preparing medicine preparation for treating swine fever |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130130 |